Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Aphton describes efficacy of Gastrimmune at two major scientific meetings

May 29, 1998

Early- and late-phase cardioprotective effects demonstrated for OPC-6535 in pig model

May 29, 1998

EP3-selective prostanoid from Ono affords cardioprotection in rabbit MI model

May 29, 1998

Reduction of colon cell proliferation associated with soy product consumption

May 29, 1998

Profile of antiarrhythmic activity of GYKI-16638, a new class Ib/III agent

May 28, 1998

p38 kinase inhibitor protects against ischemic cell death in preclinical model

May 28, 1998

Phase I results presented for Sch-58500, Schering-Plough's p53-based cancer gene therapy

May 28, 1998

Fujisawa presents new cephalosporin with good anti-H. pylori activity

May 28, 1998

5-HT4 derivative R-093877 enhances colonic transit in healthy volunteers

May 28, 1998

RSR13 enhances effects of radiotherapy in patients with glioblastoma

May 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...